b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31982173</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>02</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Print">0151-9638</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>147</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Mar</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Annales de dermatologie et de venereologie</Title>\n                <ISOAbbreviation>Ann Dermatol Venereol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Bullous lichen planus and anti-programmed cell death-1 therapy: Case report and literature review.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>221-227</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0151-9638(19)31085-3</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.annder.2019.07.008</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cutaneous adverse effects of immunotherapies are being seen with increasing frequency in general practice. While anti-PD1 lichenoid reactions are well known, only a few cases of bullous lichen planus have so far been reported in the medical literature. Herein we described a case of secondary bullous lichen planus associated with nivolumab and we present a systematic review of all anti-P1-induced cases reported in the literature.</AbstractText>\n                <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Three months after beginning treatment with nivolumab for metastatic clear-cell renal carcinoma, a 68-year-old man presented pruritic purplish papules on his limbs that subsequently became bullous. Clinical-histological correlation led us to a diagnosis of secondary bullous lichen planus induced by nivolumab. Systemic steroids and withdrawal of immunotherapy resulted in clinical improvement.</AbstractText>\n                <AbstractText Label="REVIEW OF THE LITERATURE" NlmCategory="METHODS">Our systematic review revealed 20 cases of lichen planus induced by anti-PD1 (nivolumab and pembrolizumab) published between 2016 and 2018, 6 of which were of the bullous form. Treatment and maintenance or discontinuation of anti-PD1 were dependent on severity.</AbstractText>\n                <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Bullous lichen planus has been reported only rarely in the context of nivolumab therapy. The timeline for development of cutaneous adverse reactions under anti-PD1 immunotherapy may last weeks or months and regular monitoring is required. Withdrawal of immunotherapy should only be considered where the outcome under systemic corticosteroids is unfavourable.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2020 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>de Lorenzi</LastName>\n                    <ForeName>C</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology and Venerealology, H\xc3\xb4pitaux Universitaires de Gen\xc3\xa8ve, 4, rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland. Electronic address: c_delorenzi@hotmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Andr\xc3\xa9</LastName>\n                    <ForeName>R</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology and Venerealology, H\xc3\xb4pitaux Universitaires de Gen\xc3\xa8ve, 4, rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Vuilleumier</LastName>\n                    <ForeName>A</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Oncology Department, H\xc3\xb4pitaux Universitaires de Gen\xc3\xa8ve, 4, rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kaya</LastName>\n                    <ForeName>G</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology and Venerealology, H\xc3\xb4pitaux Universitaires de Gen\xc3\xa8ve, 4, rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Abosaleh</LastName>\n                    <ForeName>M</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology and Venerealology, H\xc3\xb4pitaux Universitaires de Gen\xc3\xa8ve, 4, rue Gabrielle-Perret-Gentil, 1205 Geneva, Switzerland.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D002363">Case Reports</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>01</Month>\n                <Day>22</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>France</Country>\n            <MedlineTA>Ann Dermatol Venereol</MedlineTA>\n            <NlmUniqueID>7702013</NlmUniqueID>\n            <ISSNLinking>0151-9638</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Bullous lichen planus</Keyword>\n            <Keyword MajorTopicYN="N">Lichen plan bulleux</Keyword>\n            <Keyword MajorTopicYN="N">Nivolumab</Keyword>\n            <Keyword MajorTopicYN="N">Pembrolizumab</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>26</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>11</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31982173</ArticleId>\n            <ArticleId IdType="pii">S0151-9638(19)31085-3</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.annder.2019.07.008</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'